Entrada Therapeutics, Inc. - COMMON STOCK (TRDA)

Historical Holders from Q4 2021 to Q3 2025

Symbol
TRDA on Nasdaq
CUSIP
29384C108
Type / Class
Equity / COMMON STOCK
Shares outstanding
37.8M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
29.6M
Holdings value
$199M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
105
Number of buys
66
Number of sells
-48
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Entrada Therapeutics, Inc. - COMMON STOCK (TRDA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ROCHE FINANCE LTD 6.9% $21M 2.57M Roche Finance Ltd Dec 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/ 6.8% $13.6M 2.57M T. Rowe Price Associates, Inc. Jun 30, 2025
BlackRock, Inc. 5.3% $16.2M 1.97M BlackRock, Inc. Dec 31, 2024
JANUS HENDERSON GROUP PLC 4% -26.7% $8.08M -$3.19M 1.52M -28.3% JANUS HENDERSON GROUP PLC Jun 30, 2025

Institutional Holders of Entrada Therapeutics, Inc. - COMMON STOCK (TRDA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 29 $168 -$1.48K $5.79 1
2025 Q2 29.6M $199M -$4.88M $6.72 105
2025 Q1 30.2M $275M -$4.48M $9.04 110
2024 Q4 30.6M $530M +$9.63M $17.29 102
2024 Q3 30.1M $481M +$6.08M $15.98 98
2024 Q2 29.7M $423M +$52.1M $14.25 82
2024 Q1 26M $369M -$4.35M $14.17 76
2023 Q4 26.3M $397M +$3.02M $15.09 61
2023 Q3 26M $411M +$4.52M $15.80 55
2023 Q2 25.8M $390M +$13.5M $15.14 56
2023 Q1 24.9M $361M +$2.52M $14.50 53
2022 Q4 24.7M $334M +$2.43M $13.52 46
2022 Q3 24.5M $386M -$2.72M $15.76 32
2022 Q2 24.8M $302M -$13M $12.18 32
2022 Q1 25.8M $243M +$2.25M $9.39 46
2021 Q4 25.4M $434M +$422M $17.12 46